Concepedia

Haben Ghermazien

HG

Statistics

Publications

5

Citations

1.3K

H-Index

5

Active since

2007

Affiliations

Technion – Israel Institute of Technology(Current)

Gilead Sciences (United States)

Haben Ghermazien is an author at Technion – Israel Institute of Technology specializing in medicine, tumor biology, and tumor microenvironment.

Top concepts

Publications per year

2007–2016

5

Publications

5

Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

Vivian Barry-Hamilton, Rhyannon Spangler, Derek Marshall et al. · Nature Medicine · 2010 · 841 citations

, , +7

Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer

Derek Marshall, Susan K. Lyman, Scott McCauley et al. · PLoS ONE · 2015 · 190 citations · Full text

, , +12

Developmental Switch in the Contribution of Presynaptic and Postsynaptic NMDA Receptors to Long-Term Depression

Rebekah Corlew, Yun Wang, Haben Ghermazien et al. · Journal of Neuroscience · 2007 · 175 citations · Full text

Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours

Shelly Zaffryar‐Eilot, Derek Marshall, Tali Voloshin et al. · Carcinogenesis · 2013 · 89 citations · Full text

, , +20

Abstract 1476: A therapeutic antibody that inhibits CD73 activity by dual mechanisms

Bryan C. Barnhart, Emanuela Sega, Aaron P. Yamniuk et al. · Cancer Research · 2016 · 12 citations

, , +19

1–5 of 5